186 related articles for article (PubMed ID: 29385383)
1. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
Blankenship C
Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
[No Abstract] [Full Text] [Related]
2. International Academy of Compounding Pharmacists' recommendations for state-based legislative and regulatory initiatives.
Miller DG
Int J Pharm Compd; 2013; 17(1):48-9. PubMed ID: 23627246
[No Abstract] [Full Text] [Related]
3. Compounding errors.
Drazen JM; Curfman GD; Baden LR; Morrissey S
N Engl J Med; 2012 Dec; 367(25):2436-7. PubMed ID: 23134355
[No Abstract] [Full Text] [Related]
4. Regulating Compounding Pharmacies.
Noble A
NCSL Legisbrief; 2016 Nov; 24(42):1-2. PubMed ID: 27911513
[No Abstract] [Full Text] [Related]
5. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
6. The "Lists": What Do They Mean?
Voliva J
Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
[No Abstract] [Full Text] [Related]
7. Regulating compounding pharmacies after NECC.
Outterson K
N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
[No Abstract] [Full Text] [Related]
8. Compounding pharmacy oversight moves ahead.
Traynor K
Am J Health Syst Pharm; 2013 Jun; 70(11):920, 922, 924. PubMed ID: 23686593
[No Abstract] [Full Text] [Related]
9. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
Yoch D
Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
[TBL] [Abstract][Full Text] [Related]
10. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
Minghetti P; Pantano D; Gennari CG; Casiraghi A
Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
[TBL] [Abstract][Full Text] [Related]
11. Regulators faulted for inadequate compounding pharmacy oversight.
Traynor K
Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891
[No Abstract] [Full Text] [Related]
12. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
[No Abstract] [Full Text] [Related]
13. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
Hinkley KN
State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
[No Abstract] [Full Text] [Related]
14. Applying Quality by Design Concepts to Pharmacy Compounding.
Timko RJ
Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
[TBL] [Abstract][Full Text] [Related]
15. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
[No Abstract] [Full Text] [Related]
16. FDA inspections find unsafe practices in compounding pharmacies.
McCarthy M
BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
[No Abstract] [Full Text] [Related]
17. Looking for solutions.
Menighan TE
Int J Pharm Compd; 2013; 17(1):4. PubMed ID: 23627240
[No Abstract] [Full Text] [Related]
18. Improving and enforcing compounding pharmacy practices to protect patients.
Pegues DA
Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
[No Abstract] [Full Text] [Related]
19. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
Williams KG
J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
[TBL] [Abstract][Full Text] [Related]
20. Drug compounding, drug safety, and the first amendment.
Dresser R
Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
